亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

丹酚酸A CAS:96574-01-5

 
 
單價 面議對比
詢價 暫無
發貨 四川成都市付款后3天內
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業會員第5年
資料未認證
保證金未繳納
詳細說明

nkl-00208
中文名稱:丹酚酸A
中文別名:丹參酚酸A
英文名稱:Salvianolic acid A
英文別名:Dan phenolic acid A; Salvianolic acid;
CAS號:96574-01-5
純度: HPLC≥98%

分子式:C26H22O10
分子量:494.45
外觀:淡黃色結晶粉末
溶解性:溶于乙醇、乙/醚
沸點: 858.7±65.0 °C | Condition
密度: 1.580±0.06 g/cm3 | Condition: Temp: 20 °C
pKa 值: 2.78±0.10 | Condition: Most Acidic Temp: 25 °C
旋光度:+41°(c=0.099,乙醇)
提取來源:唇形科植物丹參
藥理藥效:抗凝血作用和顯著的抗血小板聚集作用,抗分泌和抗潰瘍作用等。
規格:10mg,20mg,50mg;可根據客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得直接用于人體

供應商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業其它產品
2”-O-沒食子?;鸾z桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |